enVVeno Medical Corp SEC filings NVNO

enVVeno Medical Corp has 415 filings in SEC EDGAR's recent list, going back to Dec 15, 2015. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jul 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

enVVeno Medical Corp SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Oct 29, 2026 —
DEF 14A Proxy statement Oct 29, 2026 Dec 10, 2026
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 15, 2026 —
4 Insider transaction Sep 14, 2026 Sep 11, 2026
144 Notice of proposed sale Sep 11, 2026 —
S-3 Shelf registration Aug 21, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Jul 14, 2026 Jul 14, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
144 Notice of proposed sale Jun 11, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Apr 29, 2026 Apr 29, 2026
S-8 Employee stock plan registration Mar 26, 2026 —
10-K Annual report Mar 26, 2026 Dec 31, 2025
4 Insider transaction Mar 13, 2026 Mar 12, 2026
144 Notice of proposed sale Mar 12, 2026 —
SCHEDULE 13D Ownership over 5% (active) Feb 20, 2026 —
SCHEDULE 13D Ownership over 5% (active) Feb 20, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 10, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 10, 2026 —
8-K Current report
Results of operations, Other events
Feb 4, 2026 Feb 4, 2026
8-K Current report
Bylaw or fiscal year change
Jan 20, 2026 Jan 20, 2026
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 15, 2025 Dec 11, 2025
4 Insider transaction Dec 15, 2025 Dec 11, 2025
4 Insider transaction Dec 15, 2025 Dec 11, 2025
4 Insider transaction Dec 15, 2025 Dec 11, 2025
4 Insider transaction Dec 12, 2025 Dec 11, 2025
8-K Current report
Shareholder vote results
Dec 12, 2025 Dec 11, 2025
DEFR14A Filing Dec 2, 2025 —
8-K Current report
Bylaw or fiscal year change
Nov 20, 2025 Nov 17, 2025
PRER14A Filing Nov 19, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 19, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
8-K Current report
Regulation FD disclosure
Nov 14, 2025 Nov 13, 2025
8-K Current report
Material agreement
Oct 30, 2025 Oct 30, 2025
424B5 Prospectus supplement Oct 30, 2025 —
DEFA14A Additional proxy material Oct 30, 2025 —
DEF 14A Proxy statement Oct 30, 2025 Dec 11, 2025
10-Q Quarterly report Oct 30, 2025 Sep 30, 2025
8-K Current report
Listing notice
Oct 10, 2025 Oct 7, 2025
4 Insider transaction Sep 17, 2025 Sep 15, 2025
144 Notice of proposed sale Sep 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Sep 9, 2025 —
8-K Current report
Regulation FD disclosure
Aug 20, 2025 Aug 20, 2025
10-Q Quarterly report Jul 31, 2025 Jun 30, 2025
4 Insider transaction May 20, 2025 May 19, 2025
3 Initial insider ownership May 20, 2025 May 19, 2025
8-K Current report
Officer or director change
May 20, 2025 May 19, 2025
10-Q Quarterly report Apr 30, 2025 Mar 31, 2025
8-K Current report
Auditor change
Apr 21, 2025 Apr 17, 2025
EFFECT Filing Mar 14, 2025 —
CORRESP Letter to the SEC Mar 14, 2025 —
S-8 Employee stock plan registration Mar 12, 2025 —
S-3/A Filing Mar 12, 2025 —
UPLOAD Letter from the SEC Mar 10, 2025 —
S-3 Shelf registration Feb 28, 2025 —
10-K/A Amended annual report Feb 28, 2025 Dec 31, 2024
10-K Annual report Feb 28, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 2, 2025 Dec 31, 2024
4 Insider transaction Dec 26, 2024 Dec 24, 2024
8-K Current report
Shareholder vote results
Dec 26, 2024 Dec 18, 2024
4 Insider transaction Dec 23, 2024 Dec 19, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 19, 2024 Dec 19, 2024
DEF 14A Proxy statement Nov 19, 2024 Dec 18, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Oct 31, 2024 Sep 30, 2024
8-K Current report
Material agreement
Sep 30, 2024 Sep 26, 2024
424B5 Prospectus supplement Sep 30, 2024 —
FWP Free writing prospectus Sep 27, 2024 —
424B5 Prospectus supplement Sep 26, 2024 —
10-Q Quarterly report Jul 31, 2024 Jun 30, 2024
S-8 Employee stock plan registration May 10, 2024 —
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Regulation FD disclosure
Apr 24, 2024 Apr 24, 2024
4 Insider transaction Mar 15, 2024 Mar 13, 2024
8-K Current report
Regulation FD disclosure
Mar 6, 2024 Mar 6, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 23, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
4 Insider transaction Dec 7, 2023 Dec 5, 2023
4 Insider transaction Dec 7, 2023 Dec 5, 2023
4 Insider transaction Dec 7, 2023 Dec 5, 2023
4 Insider transaction Dec 7, 2023 Dec 5, 2023
4 Insider transaction Dec 7, 2023 Dec 5, 2023
4 Insider transaction Dec 7, 2023 Dec 5, 2023
4 Insider transaction Dec 7, 2023 Dec 5, 2023
4 Insider transaction Dec 7, 2023 Dec 5, 2023
8-K Current report
Shareholder vote results
Dec 7, 2023 Dec 5, 2023
8-K Current report
Regulation FD disclosure
Nov 16, 2023 Nov 16, 2023
EFFECT Filing Nov 3, 2023 —
DEF 14A Proxy statement Nov 3, 2023 Nov 3, 2023
CORRESP Letter to the SEC Nov 1, 2023 —
UPLOAD Letter from the SEC Oct 31, 2023 —
S-3 Shelf registration Oct 26, 2023 —
10-Q Quarterly report Oct 26, 2023 Sep 30, 2023
8-K Current report
Material agreement, Unregistered share sale
Oct 12, 2023 Oct 6, 2023
EFFECT Filing Aug 23, 2023 —
CORRESP Letter to the SEC Aug 21, 2023 —
S-3/A Filing Aug 14, 2023 —
UPLOAD Letter from the SEC Aug 7, 2023 —
S-3 Shelf registration Jul 31, 2023 —
10-Q Quarterly report Jul 31, 2023 Jun 30, 2023
25-NSE Delisting notice May 26, 2023 —
424B3 Prospectus May 5, 2023 —
10-Q Quarterly report Apr 28, 2023 Mar 31, 2023
10-K Annual report Mar 2, 2023 Dec 31, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
3 Initial insider ownership Jan 31, 2023 Jan 18, 2023
8-K Current report
Shareholder vote results
Dec 6, 2022 Nov 30, 2022
4 Insider transaction Dec 2, 2022 Nov 30, 2022
4 Insider transaction Dec 2, 2022 Nov 30, 2022
4 Insider transaction Dec 2, 2022 Nov 30, 2022
4 Insider transaction Dec 2, 2022 Nov 30, 2022
DEF 14A Proxy statement Nov 1, 2022 Nov 1, 2022
10-Q Quarterly report Oct 27, 2022 Sep 30, 2022
4 Insider transaction Sep 16, 2022 Sep 13, 2022
4 Insider transaction Sep 16, 2022 Sep 13, 2022
4 Insider transaction Aug 18, 2022 Aug 16, 2022
10-Q Quarterly report Aug 3, 2022 Jun 30, 2022
4 Insider transaction Jul 1, 2022 Jun 30, 2022
4 Insider transaction Jun 28, 2022 Jun 27, 2022
UPLOAD Letter from the SEC May 16, 2022 —
10-Q/A Amended quarterly report May 11, 2022 Mar 31, 2022
10-K/A Amended annual report May 11, 2022 Dec 31, 2021
CORRESP Letter to the SEC May 11, 2022 —
UPLOAD Letter from the SEC May 6, 2022 —
10-Q Quarterly report Apr 29, 2022 Mar 31, 2022
S-8 Employee stock plan registration Apr 18, 2022 —
10-K Annual report Mar 28, 2022 Dec 31, 2021
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 11, 2022 —
SC 13G/A Amended ownership over 5% (passive) Jan 19, 2022 —
8-K/A Amended current report
Shareholder vote results
Dec 3, 2021 Nov 30, 2021
4 Insider transaction Dec 2, 2021 Nov 30, 2021
4 Insider transaction Dec 2, 2021 Nov 30, 2021
4 Insider transaction Dec 2, 2021 Nov 30, 2021
4 Insider transaction Dec 2, 2021 Nov 30, 2021
4 Insider transaction Dec 2, 2021 Nov 30, 2021
4 Insider transaction Dec 2, 2021 Nov 30, 2021
4 Insider transaction Dec 2, 2021 Nov 30, 2021
8-K Current report
Shareholder vote results, Regulation FD disclosure
Dec 1, 2021 Nov 30, 2021
4 Insider transaction Nov 19, 2021 Nov 19, 2021
4 Insider transaction Nov 18, 2021 Nov 16, 2021
4 Insider transaction Nov 18, 2021 Nov 16, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
DEF 14A Proxy statement Nov 2, 2021 Nov 1, 2021
8-K Current report
Bylaw or fiscal year change
Oct 1, 2021 Sep 29, 2021
8-K Current report
Other events
Sep 22, 2021 Sep 21, 2021
SC 13G Ownership over 5% (passive) Sep 17, 2021 —
4 Insider transaction Sep 15, 2021 Sep 13, 2021
4 Insider transaction Sep 15, 2021 Sep 13, 2021
8-K Current report
Material agreement
Sep 8, 2021 Sep 3, 2021
424B5 Prospectus supplement Sep 8, 2021 —
4 Insider transaction Aug 27, 2021 Aug 25, 2021
8-K Current report
Material agreement
Aug 12, 2021 Aug 12, 2021
424B5 Prospectus supplement Aug 12, 2021 —
10-Q Quarterly report Aug 11, 2021 Jun 30, 2021
424B3 Prospectus Aug 6, 2021 —
4 Insider transaction Jun 21, 2021 Jun 16, 2021
S-8 Employee stock plan registration May 26, 2021 —
4 Insider transaction May 25, 2021 May 21, 2021
4 Insider transaction May 19, 2021 May 18, 2021
4 Insider transaction May 19, 2021 May 17, 2021
10-Q Quarterly report May 12, 2021 Mar 31, 2021
EFFECT Filing May 6, 2021 —
POS AM Filing Apr 30, 2021 —
10-K Annual report Mar 31, 2021 Dec 31, 2020
8-K Current report
Officer or director change
Feb 24, 2021 Feb 18, 2021
4 Insider transaction Feb 23, 2021 Jul 18, 2020
3 Initial insider ownership Feb 23, 2021 Apr 6, 2020
4 Insider transaction Feb 22, 2021 Feb 18, 2021
4 Insider transaction Feb 22, 2021 Feb 18, 2021
4 Insider transaction Feb 22, 2021 Feb 18, 2021
4 Insider transaction Feb 22, 2021 Feb 18, 2021
4 Insider transaction Feb 22, 2021 Feb 18, 2021
4 Insider transaction Feb 22, 2021 Feb 18, 2021
SC 13G Ownership over 5% (passive) Feb 19, 2021 —
SC 13G Ownership over 5% (passive) Feb 17, 2021 —
8-K Current report
Material agreement, Other events
Feb 12, 2021 Feb 12, 2021
424B4 Prospectus Feb 10, 2021 —
EFFECT Filing Feb 8, 2021 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
NVNO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Irvine, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1661053
Former names
Hancock Jaffe Laboratories, Inc. (until Sep 22, 2021)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.